Farms.com Home   News

GMO crops and glyphosate use can offer carbon sequestration benefits, Canadian study suggests

University of Saskatchewan research has concluded that genetically modified canola and the use of glyphosate have increased carbon sequestration in the soil and reduced CO2 emissions from Canadian farmland.

“There is a complementary relationship between the adoption of herbicide-tolerant (HT) canola and conservation tillage, resulting in corresponding changes in GHG emissions,” says a paper published in the journal Sustainability in October. “Saskatchewan farmers have confirmed just how crucial the use of glyphosate is with the complementary technology of HT crops… (to) maintain sustainable land management practices.”

After estimating the changes in soil organic carbon, the authors estimated the change in carbon sequestration from minimal tillage and less summerfallow.

They pegged increased carbon sequestration at “0.14 Mg/ha (tonnes per hectare) from reductions in tillage practices and 0.39 Mg/ha from reductions in summerfallow practices.”

Many of these benefits occurred because of GM canola and glyphosate, the authors said.

Other scientists are less convinced about the benefits of zero-tillage when it comes to improving soil organic carbon.

University of Guelph researchers have found that soil organic carbon in the soil profile is the same in no-till and conventionally tilled systems, even in soil that has been zero tillage for decades.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.